May 22, 2023 Post navigation PDS Biotech Completes Enrollment in Immune Checkpoint Inhibitor Naïve Arm of VERSATILE-002 Phase 2 Clinical Trial in Advanced HPV16 Positive Head and Neck CancerNetScientific hails deal inked by investee company Sofant